Frontlight ResearchEarly access
Trial site
The Oncology Institute of Hope and Innovation
- 4running trials
The trials here
What the 4 trials at this site are about, from their registry records.
- Conditions
- Lung cancer3 trials
- Colorectal cancer1 trial
- Gastric and oesophageal cancer1 trial
- Metastatic breast cancer1 trial
- Pancreatic cancer1 trial
- Phase
- Phase 1/22 trials
- Phase 22 trials
- Status
- Active, not recruiting3 trials
- Recruiting1 trial
- Lead sponsor
- Janssen Research & Development, LLC2 trials
- Boehringer Ingelheim1 trial
- Partner Therapeutics, Inc.1 trial
Running trials
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
A Study of Zenocutuzumab (MCLA-128) in Patients With Solid Tumors Harboring an NRG1 Fusion (eNRGy)
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Colorectal cancer1 recruiting
- Gastric and oesophageal cancer1 recruiting
- Metastatic breast cancer1 recruiting
Site data: ClinicalTrials.govUpdated 17 Nov 2026